Literature DB >> 11953455

FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling.

Wen-Hua Zheng1, Satyabrata Kar, Rémi Quirion.   

Abstract

We report that the Forkhead family of transcription factors, FKHRL1, FKHR and AFX are novel components of neurotrophin receptor signaling. NGF rapidly induced the phosphorylation of FKHRL1 in PC12 cells. This effect is mediated by high-affinity TrkA receptor as nerve growth factor (NGF) induced the phosphorylation of FKHRL1 only in TrkA expressing cells and not p75-expressing cells. Additional experiments with various kinase inhibitors, the transient expression of constitutively active and dominant-negative Akt, and in vitro kinase assay revealed that phosphatidylinositol-3 (PtdIns3)/Akt kinase mediated the actions of NGF. Similar data were obtained for brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4) in primary cortical cultured neurons. These findings demonstrate for the first time that the phosphorylation of the Forkhead family of transcription factors can be modulated by neurotrophins via Trk receptors and PtdIns3K/Akt kinase (but not MAP or S6p70 kinases) in neuronal and non-neuronal cells. Moreover, survival assays with the PtdIns3 kinase inhibitor LY294002, active and dominant-negative forms of Akt indicate that the phosphorylation of FKHRL1 plays a role in neurotrophins-mediated cell survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953455     DOI: 10.1046/j.0022-3042.2002.00783.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  42 in total

Review 1.  Forkhead family transcription factor FoxO and neural differentiation.

Authors:  Qiang Wen; Haitao Wang; Peter J Little; Remi Quirion; Wenhua Zheng
Journal:  Neurogenetics       Date:  2012-03-28       Impact factor: 2.660

Review 2.  Apoptotic cell death regulation in neurons.

Authors:  Emilie Hollville; Selena E Romero; Mohanish Deshmukh
Journal:  FEBS J       Date:  2019-07-12       Impact factor: 5.542

Review 3.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

4.  The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells.

Authors:  Haitao Wang; Xuanhe Zhou; Jianchu Huang; Nan Mu; Zeli Guo; Qiang Wen; Rikang Wang; Shaorui Chen; Zhong-Ping Feng; Wenhua Zheng
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

5.  Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.

Authors:  Cristina Malagelada; Zong Hao Jin; Vernice Jackson-Lewis; Serge Przedborski; Lloyd A Greene
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

Review 6.  Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

Review 7.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

8.  Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.

Authors:  Abigail Polter; Sufen Yang; Anna A Zmijewska; Thomas van Groen; Ji-Hye Paik; Ronald A Depinho; Stanford L Peng; Richard S Jope; Xiaohua Li
Journal:  Biol Psychiatry       Date:  2008-09-27       Impact factor: 13.382

Review 9.  Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Biomed Pharmacother       Date:  2008-02-20       Impact factor: 6.529

10.  Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis.

Authors:  Petra Obexer; Judith Hagenbuchner; Thomas Unterkircher; Nora Sachsenmaier; Christoph Seifarth; Günther Böck; Verena Porto; Kathrin Geiger; Michael Ausserlechner
Journal:  Mol Biol Cell       Date:  2009-02-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.